back
Inkjet printing of bio-molecules
CSEM SA
CSEM is a privately held, R&D center established in 1984 in Neuchâtel, Switzerland. From the beginning, CSEM has been committed to both applied and order-related R&D. This bridge function between economics and science is still a core aspect of the company, and CSEM has continuously adapted its research areas to the needs of industry.
MedPhab partner
[TECHNICAL] TECHNICAL SERVICES
Integration Post-Processing
INTEGRATION [Surface activation] Bio-reagent dispense
IN4 Surface activation
Bio-reagent dispense
PP4 Thin film deposition
Sheet/wafer liquid phase
in vitro diagnostics in vivo diagnostics therapeutics others
Technology provider Supplier Manufacturer Production services Integrator R&D
Highly controlled deposition of biomolecules using inkjet printing for various applications (e.g. biosensing, tissue engineering, organ-on-chip).
Multilayer alingment semi-automatic
print resolution 50 um
Applications bio-molecule dispensing
Drop volume 1 to 10 pL
Post-processing options UV
printable liquids water-based buffers
Max. substrate size A4 (297x210mm) production volume unit
Max. substrate thickness 8 mm
Printing speed Depends on layout feature density
Highly controlled deposition of biomolecules using inkjet printing for various applications (e.g. biosensing, tissue engineering, organ-on-chip).
CSEM IN4 0004 V1.0
2 3 4 5
1 2 3 4 5
ISO 9001
Typically up to 100 samples per month